From: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Mechanism | Type | Compound | References |
---|---|---|---|
Inhibitor of MYC/Max dimerization | Small Molecule | IIA6B17 | [672] |
10058-F4 | [673] | ||
10074-G5 | [674] | ||
JY-3-094 | [675] | ||
3jc48–3 | [676] | ||
MYCro1, MYCro2, MYCro3 | [677] | ||
MYCMI-6 | [676] | ||
KJ-Pyr-9 | [678] | ||
EN4 | [679] | ||
MYCi361 | [680] | ||
MYCi975 | [681] | ||
KI-MS2-008 | [682] | ||
(Poly)peptide | OmoMYC | [683] | |
FPPa-OmoMYC | [684] | ||
Max bHLHZ (OmoMYC) | [685] | ||
Mxd1 | [686] | ||
Monoclonal antibody | [687] | ||
H1 peptide | [688] | ||
Inhibitor of E-box binding | Small Molecule | JKY-2-169 | [689] |
(Poly)peptide | OmoMYC | [683] | |
Max bHLHZ | [685] | ||
Mxd1 | [686] | ||
ME47 | [690] |